查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1886804

全球肺癌手术市场

Lung Cancer Surgery
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 279 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球肺癌手术市场规模将达83亿美元。

2024年全球肺癌手术市场规模估计为65亿美元，预计2030年将达83亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.2%。本报告分析的细分市场之一－开放式手术，预计复合年增长率为4.1%，到分析期末将达到58亿美元。微创手术细分市场预计在分析期间内复合年增长率为4.6%。

美国市场规模估计为17亿美元，而中国市场预计将以6.5%的复合年增长率成长。

据估计，2024年美国肺癌手术市场规模将达17亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到18亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）为6.5%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，两国的复合年增长率分别为2.7%和3.2%。在欧洲，德国的复合年增长率预计约为3.3%。

全球肺癌手术市场－主要市场趋势与驱动因素概述

为什么肺癌手术是现代癌症治疗中如此重要的组成部分？

肺癌仍然是全球最常见且致死率最高的癌症之一，因此，手术等有效治疗方法在对抗这种疾病中至关重要。肺癌手术包括切除肿瘤以及癌细胞可能扩散的周边肺组织。这种方法通常对局部、可手术的非小细胞肺癌（NSCLC）最有效，尤其是在肺癌早期阶段。外科技术的进步，包括微创手术（如胸腔镜辅助手术（VATS）和机器人辅助手术），显着改善了患者的预后。与传统手术（开放性手术）相比，这些技术可以减轻患者的身体负担和缩短恢復时间，降低併发症风险，并提高术后生活品质。筛检方法的改进使得更多肺癌能够在可手术阶段得到诊断，手术在治疗方案製定中的作用也不断扩大。

技术创新如何改变肺癌手术？

肺癌外科领域因技术进步而发生变革，这些进步使得手术更加精准、微创。例如，机器人手术等创新技术赋予外科医生更大的操作灵活性和控制力，使他们能够进行复杂的组织分离，并在切除肿瘤的同时最大限度地保护健康组织。此外，即时电脑断层扫描和萤光成像等术中影像技术提高了肿瘤定位和切缘评估的准确性，使得在初次手术中能够切除更多癌组织。这些进步不仅提高了手术成功率，而且最大限度地减轻了患者的身体负担，从而缩短了恢復时间，减少了术后不适。

早期发现及个人化治疗如何影响肺癌手术效果？

早期发现和个人化治疗方案对肺癌手术疗效有显着影响。低剂量CT筛检在高风险族群的应用，使得肺癌的早期诊断得以实现。这增加了在可手术切除阶段发现的病例数量，提高了根治性的可能性。个人化医疗利用肿瘤基因谱分析来了解肿瘤特征，在筛选适合手术的患者以及预测其对化疗和标靶治疗等辅助治疗的反应方面也取得了长足进展。这种个人化方法能够制定出最大限度提高手术疗效、最大限度减少不必要治疗的治疗方案，从而提高患者的生存率和生活品质。

肺癌手术市场成长受多种因素驱动

肺癌手术市场的成长受多种因素驱动，包括技术进步、筛检方法改进以及对个人化医疗的日益重视。微创手术和机器人辅助手术等外科技术的创新，拓展了手术适应症范围，改善了患者预后，并使手术成为许多患者更现实的选择。筛检计画的加强也发挥关键作用，提高了早期癌症的检出率，而早期手术介入最为有效。此外，对肺癌遗传基础的深入了解，使得个人化手术治疗更加普及，从而能够进行更有针对性、更有效的介入。这些进展，加上人们对肺癌风险和预防意识的提高，持续推动肺癌手术治疗的需求，反映出一个充满活力且不断发展的市场。

部分：

外科手术（开放性手术、微创手术）、医疗设备（手术器材、监测及视觉化系统、内视镜手术设备）

受访公司范例

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片文字稿、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP13120

Global Lung Cancer Surgery Market to Reach US$8.3 Billion by 2030

The global market for Lung Cancer Surgery estimated at US$6.5 Billion in the year 2024, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Thoracotomy, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Minimally Invasive Surgery segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 6.5% CAGR

The Lung Cancer Surgery market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Lung Cancer Surgery Market - Key Trends & Drivers Summarized

Why Is Lung Cancer Surgery a Critical Component of Cancer Treatment Today?

Lung cancer remains one of the most prevalent and deadly cancers worldwide, making effective treatment modalities like surgery crucial in the fight against this disease. Surgery for lung cancer involves the removal of the tumor and surrounding lung tissue where cancer cells may have spread. This approach is generally most effective in the early stages of lung cancer, specifically non-small cell lung cancer (NSCLC), where the tumor is localized and operable. Advances in surgical techniques, including minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robot-assisted surgery, have significantly improved outcomes for patients. These techniques reduce surgical trauma and recovery time, decrease the risk of complications, and can improve the quality of life post-surgery compared to traditional open surgery. As detection methods improve and more lung cancers are diagnosed at an operable stage, the role of surgery in treatment regimens continues to expand.

How Are Technological Advances Transforming Lung Cancer Surgery?

The landscape of lung cancer surgery has been transformed by technological advancements that allow for more precise and less invasive procedures. Innovations such as robotic surgery provide surgeons with enhanced dexterity and control, enabling them to perform complex dissections and remove tumors with high precision while preserving healthy tissue. Furthermore, intraoperative imaging technologies like real-time CT scans and fluorescence imaging have improved the accuracy of tumor localization and the assessment of resection margins, ensuring that more of the cancerous tissue is removed during the initial surgery. These advancements not only increase the success rate of surgical interventions but also minimize the physical impact on patients, leading to faster recovery times and less postoperative discomfort.

What Impact Do Early Detection and Personalized Treatment Have on Lung Cancer Surgery Outcomes?

Early detection and personalized treatment approaches are significantly influencing outcomes in lung cancer surgery. The development of low-dose CT screening for high-risk individuals has led to earlier diagnosis of lung cancer, often at a stage when surgical resection is possible and more likely to be curative. Personalized medicine, which involves genetic profiling of tumors to understand their unique characteristics, has also made strides in determining which patients are good candidates for surgery and how they might best respond to additional treatments such as chemotherapy or targeted therapy. This tailored approach helps in strategizing treatment plans that maximize the efficacy of surgery and minimize unnecessary treatments, thereby improving overall patient survival and quality of life.

Growth in the Lung Cancer Surgery Market Is Driven by Several Factors

The growth in the lung cancer surgery market is driven by several factors, encompassing technological advancements, improved detection methods, and an increased emphasis on personalized medicine. Technological innovations in surgical techniques, including minimally invasive and robotic-assisted surgeries, have broadened the range of operable cases and improved patient outcomes, making surgery a more viable option for many patients. Enhanced screening programs have also played a critical role, as they increase the number of early-stage cancers identified, where surgical intervention can be most beneficial. Additionally, as understanding of the genetic basis of lung cancer improves, personalized surgical treatments are becoming more prevalent, allowing for more targeted and effective interventions. These developments, combined with a growing awareness of lung cancer risks and prevention, continue to drive the demand for surgical solutions in the treatment of lung cancer, reflecting a dynamic and evolving marketplace.

SCOPE OF STUDY:

The report analyzes the Lung Cancer Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure (Thoracotomy, Minimally Invasive Surgery); Device (Surgical Instruments, Monitoring & Visualizing Systems, Endosurgical Equipment)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 111 Featured) -

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Lung Cancer Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Minimally Invasive Surgical Techniques Propel Growth in Lung Cancer Surgery
    • Integration of Robotic-Assisted Systems Accelerates Demand for Precision Lung Cancer Surgery
    • Innovations in Imaging and Intraoperative Navigation Expand the Addressable Market Opportunity for Lung Cancer Surgery
    • Enhanced Preoperative Diagnostics Drives Adoption of Targeted Lung Cancer Surgical Procedures
    • Digital Transformation in Surgical Planning Generates Demand for Advanced Lung Cancer Surgery Technologies
    • Rising Incidence of Lung Cancer Strengthens the Business Case for Cutting-Edge Surgical Interventions
    • Increasing Adoption of Personalized Treatment Protocols Spurs Growth in Demand for Lung Cancer Surgery
    • Enhanced Multidisciplinary Care Models Throws the Spotlight On Comprehensive Lung Cancer Surgery Approaches
    • Strategic Collaborations Between Medical Device Manufacturers and Healthcare Providers Propel Innovation in Lung Cancer Surgery
    • Integration of AI and Machine Learning in Treatment Planning Accelerates Demand for Next-Generation Lung Cancer Surgery
    • Advances in Intraoperative Imaging and Real-Time Monitoring Generate Opportunities for Improved Surgical Precision
    • Shifting Regulatory Standards for Cancer Treatment Drive Adoption of Advanced Lung Cancer Surgery Techniques
    • Emergence of Targeted Therapies and Neoadjuvant Treatments Expands the Market for Lung Cancer Surgical Solutions
    • Enhanced Recovery After Surgery Protocols Strengthen the Business Case for Minimally Invasive Lung Cancer Surgery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Thoracotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Monitoring & Visualizing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Lung Cancer Surgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Endosurgical Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • JAPAN
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • CHINA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • EUROPE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • FRANCE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • GERMANY
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • INDIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030
  • AFRICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2015, 2025 & 2030

IV. COMPETITION